Lemonade

LMND · NYSE

$45.40+$2.25 (+5.21%)TodayMarket closed · Oct 20, 7:39 PM ET

Prev close $43.15

LMND analyst rating

BuyConsensus of 7 analysts over the last 12 months. 57% rate it a buy.

Strong buy0
Buy4
Hold3
Underperform0
Sell0

12-month price target · 12 analysts

Average $65.23 (+43.7% upside)

Low: $37.37
Now: $45.40
High: $111.84

Upgrades and downgrades

The latest rating actions, newest first

LMND analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Oct 6, 2026	Maintains	Equal-Weight	$56.00 → $48.00	49%
Morgan Stanley	Aug 19, 2026	Maintains	Equal-Weight	$65.00 → $56.00	49%
Piper Sandler	Jul 30, 2026	Maintains	Neutral	$75.00 → $51.00	73%
Keefe, Bruyette & Woods	Jul 30, 2026	Upgrade	Underperform → Market Perform	$48.00	61%
Piper Sandler	Jul 15, 2026	Maintains	Neutral	$62.00 → $75.00	73%
Keefe, Bruyette & Woods	Jul 8, 2026	Maintains	Underperform	$44.00 → $48.00	61%
Morgan Stanley	Jul 8, 2026	Downgrade	Overweight → Equal-Weight	$75.00	49%
Morgan Stanley	May 21, 2026	Maintains	Overweight	$80.00 → $75.00	49%
Piper Sandler	Apr 30, 2026	Maintains	Neutral	$65.00 → $62.00	73%
Citizens	Apr 30, 2026	Maintains	Market Outperform	$85.00 → $80.00	72%

The case for and against

Updated Oct 17, 2026

Bull case

Lemonade is viewed positively because its AI-first insurance platform is already producing clear operating leverage: over the past three years premiums doubled while the LAE ratio fell from 13% to 6%, ~80% of claims are now handled without human involvement, and headcount has declined -6% since 4Q22 even as the business scaled. The company is also demonstrating strong growth and underwriting improvement, with 1Q26 revenue of $258.0M, adjusted gross profit of $101M, in-force premium of $1.333B, and a TTM gross loss ratio of 61% that improved 12 percentage points YoY, alongside 10 straight quarters of accelerating IFP growth. Its outlook is further supported by expanding growth vectors in Lemonade Car, Lemonade Pet surpassing $500M in IFP, and Europe’s 103% quarterly IFP growth across four countries, all of which reinforce the path toward EBITDA profitability in 4Q26 and beyond.

Bear case

Lemonade is still showing underwriting progress, but the investment case remains challenged by only gradual progress toward adjusted EBITDA profitability, now targeted for 4Q26, and by dependence on initiatives that are still early such as cross-sell expansion and autonomous optimization in 2026. While net customer adds and a 7% increase in premiums per customer outside home support momentum, the home business continues to decline, the autonomous car product remains limited to a few states, and elevated gross loss ratios in home and Europe raise concern about underwriting quality. The negative view is further reinforced by higher stock-based compensation tied to a multiyear grant, investor disappointment with the less impressive loss-ratio improvement, and ongoing risks from regulation, reinsurance, customer acquisition costs, and AI competition.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.